- Home
- JCTC vs APTO Comparison
JCTC vs APTO Comparison
Compare JCTC & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCTC
- APTO
- Stock Information
- Founded
- JCTC 1953
- APTO 1986
- Country
- JCTC United States
- APTO Canada
- Employees
- JCTC N/A
- APTO N/A
- Industry
- JCTC
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JCTC
- APTO Health Care
- Exchange
- JCTC NYSE
- APTO Nasdaq
- Market Cap
- JCTC 15.9M
- APTO 13.2M
- IPO Year
- JCTC 1996
- APTO N/A
- Fundamental
- Price
- JCTC $4.87
- APTO $0.16
- Analyst Decision
- JCTC
- APTO Strong Buy
- Analyst Count
- JCTC 0
- APTO 3
- Target Price
- JCTC N/A
- APTO $4.33
- AVG Volume (30 Days)
- JCTC 8.7K
- APTO 17.4M
- Earning Date
- JCTC 04-14-2025
- APTO 03-25-2025
- Dividend Yield
- JCTC N/A
- APTO N/A
- EPS Growth
- JCTC N/A
- APTO N/A
- EPS
- JCTC N/A
- APTO N/A
- Revenue
- JCTC $46,606,336.00
- APTO N/A
- Revenue This Year
- JCTC N/A
- APTO N/A
- Revenue Next Year
- JCTC N/A
- APTO N/A
- P/E Ratio
- JCTC N/A
- APTO N/A
- Revenue Growth
- JCTC N/A
- APTO N/A
- 52 Week Low
- JCTC $3.86
- APTO $0.13
- 52 Week High
- JCTC $5.71
- APTO $1.94
- Technical
- Relative Strength Index (RSI)
- JCTC N/A
- APTO 42.85
- Support Level
- JCTC N/A
- APTO $0.13
- Resistance Level
- JCTC N/A
- APTO $0.26
- Average True Range (ATR)
- JCTC 0.00
- APTO 0.02
- MACD
- JCTC 0.00
- APTO -0.00
- Stochastic Oscillator
- JCTC 0.00
- APTO 24.69
About JCTC JEWETT-CAMERON TRADING CO
Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.